Why does anybody own CRISPR? An argument against academic IP – MedCity News
MedCity News |
Why does anybody own CRISPR? An argument against academic IP
MedCity News “I've seen many examples, both in companies I'm associated with and other people, of people who could make use of CRISPR in very big and important ways, but are doing other things that are slower, more expensive, less efficient, because they are … |
